Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial-Reference-Cited by-同舟云学术

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

Published:2012-05 Issue:9 Volume:52 Page:1658-1665
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Loguercio Carmela,Andreone Pietro,Brisc Ciprian,Brisc Michaela Cristina,Bugianesi Elisabetta,Chiaramonte Maria,Cursaro Carmela,Danila Mirela,de Sio Ilario,Floreani Annarosa,Freni Maria Antonietta,Grieco Antonio,Groppo Marzia,Lazzari Roberta,Lobello Salvatore,Lorefice Elisabetta,Margotti Marzia,Miele Luca,Milani Stefano,Okolicsanyi Lajos,Palasciano Giuseppe,Portincasa Piero,Saltarelli Patrizia,Smedile Antonina,Somalvico Francesco,Spadaro Aldo,Sporea Ioan,Sorrentino Paolo,Vecchione Raffaela,Tuccillo Concetta,Blanco Camillo Del Vecchio,Federico Alessandro

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference59 articles.

1. Risk of cardiovascular disease in patients with non alcoholic fatty liver disease;Targher;N. Engl. J. Med.,2010

2. Hepatic steatosis in hepatitis C: comparison of diabetic and non-diabetic patients in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis Trial;Lok;Clin. Gastroenterol. Hepatol.,2007

3. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

4. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis;Sanyal;N. Engl. J. Med.,2010

5. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease;Musso;Hepatology,2010

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial;Clinical Nutrition ESPEN;2024-10

2. Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial;Medicina;2024-08-21

3. Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial;Lipids in Health and Disease;2024-08-03

4. Phytosome: Recent Investigation for a New Drug Delivery System;International Journal of Newgen Research in Pharmacy & Healthcare;2024-06-30

5. The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review;Antioxidants;2024-06-29